Company: MBIO
Filing Date: 2025-12-03
Form Type: DEF 14A
Source: 0001104659-25-118122
Chunk: 53

Company: MUSTANG BIO, INC.
Filing Date: 2025-12-03
Form: DEF 14A
Chunk 53
---
 to Participants within sixty (60) days following the Change in Control (unless a later date is required by Section 16.3 hereof), based upon the length of time within the performance period that has elapsed prior to the Change in Control. Any Awards shall thereafter continue or lapse in accordance with the other provisions of the EIP and the Award Certificate. To the extent that this provision causes Incentive Stock Options to exceed the dollar limitation set forth in IRC Section 422(d), the excess Options shall be deemed to be Nonstatutory Stock Options.**

<div align='center'>35</div>

**Discretionary Acceleration.The Compensation Committee may, in its discretion, accelerate the vesting and/or payment of any awards for any reason, subject to certain limitations under Section 409A of the IRC. The Compensation Committee may discriminate among participants or among awards in exercising such discretion.

Certain Transactions.Upon the occurrence or in anticipation of certain corporate events or extraordinary transactions, the Compensation Committee may also make discretionary adjustments to awards, including settling awards for cash, providing that awards will become fully vested and exercisable, providing for awards to be assumed or substituted, or modifying performance targets or periods for awards.

Termination and Amendment.Unless earlier terminated as provided in the EIP, the EIP will terminate on the tenth (10) anniversary of its adoption, or, if the stockholders approve this proposal three, the tenth (10) anniversary of the date of such approval, unless earlier terminated by our Board or Compensation Committee.

The Board or the Committee may, at any time and from time to time, amend, modify or terminate the EIP without stockholder approval; however, if an amendment to the EIP would, in the reasonable opinion of the Board or the Committee, constitute a material change requiring stockholder approval under applicable laws, policies or regulations or the applicable listing or other requirements of an Exchange, then such amendment shall be subject to stockholder approval; and provided, further, that the Board or Committee may condition any other amendment or modification on the approval of stockholders of the Company for any reason, including by reason of such approval being necessary or deemed advisable (i) to comply with the listing or other requirements of an Exchange, or (ii) to satisfy any other tax, securities or other applicable laws, policies or regulations. Except for any mandatory adjustments to the EIP and Awards required under the EIP, without the prior approval of the stockholders of the Company, the EIP may not be amended to permit: (i)